Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Zymeworks
|
| gptkbp:CEO |
gptkb:M._Scott_Whitcup
|
| gptkbp:clinicalTrials |
Phase 2 trials
|
| gptkbp:collaborations |
gptkb:AstraZeneca
|
| gptkbp:focus |
immuno-oncology
|
| gptkbp:founded |
2011
|
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
IOVA
|
| gptkbp:investmentFocus |
Venture capital firms
|
| gptkbp:keyFigures |
TAVO
|
| gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:researchAreas |
cancer treatment
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:tributaryOf |
multiple drug candidates
|
| gptkbp:website |
www.iovance.com
|